About
Dave Duncan joined Finistere Ventures as Venture Partner in 2017. LLC Before joining FBSciences, Dave Duncan was CEO of Pasteuria Bioscience, where he led the company through its first successful EPA registration and commercial launch of a biological nematicide for use on turf grass; and, most recently completed an exclusive technology partnership with Syngenta. In his role as CEO for Chlorogen, Dave Duncan helped raise $10M in two series of financing for the young biopharmaceutical company that developed and manufactured proteins for human therapy. Dave Duncan also served in various roles, including product development (US & Canada); marketing; government and regulatory affairs; and as both a commercial development and business unit executive during his 22 years at Monsanto Company. He was credited for helping the company transition from a traditional agricultural chemical company into the world's leading producer of agricultural biotechnology products. Dave Duncan received a B.S. de
Position in the VCSift Database
- • 8 investors at Finistere Ventures are tracked.
- • 421 investors hold the Venture Partner role in VCSift. Dave Duncan is one of them.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Collierville, US
Contact Information
Find more investors like Dave
Search Investors